Skip to main content
. 2023 Jul 5;49(7):831–839. doi: 10.1007/s00134-023-07141-5
The use of erythropoietin in patients treated in the intensive-care unit after severe or moderate traumatic brain injury does not improve very long-term outcome, even though uncertainty remains, and further studies are needed.